SOD1 and amyotrophic lateral sclerosis: In the SOD1-G93A mouse model of familial amyotrophic lateral sclerosis (ALS), the elevation of PGC1α levels sustained mitochondrial biogenesis through end-stage disease and this activity was accompanied by retention of muscle function, delayed muscle atrophy, and significantly improved muscle endurance even at late stages of disease.